Guidelines and training programs should be developed to assist he

Guidelines and training programs should be developed to assist health professionals in discussing the communication

needs of patients. 3. Health professionals may decide, depending on relevant legal and ethical considerations, to override a patient’s objection to informing family members and inform them him or herself. However, both the professional and patient are best served by the patient informing his or her own family members, or at very least authorizing a health professional to do so. Conclusion Knowledge of one’s risk and genetic information is an important step towards early detection GDC 0032 cost or prevention of hereditary

breast cancer. Information about risk can come from family history, from a family member who has been tested for a genetic mutation, or from use of a risk prediction model. Although the only way to know for sure that one has the same mutation is to be tested or diagnosed, often it is these other various sources of information that lead a person to be tested in the first place. It has thus been questioned whether a person who knows or strongly suspects they carry a mutation must share this information Pevonedistat cost with others in their family. In brief, we have discussed a number of key considerations that Y-27632 2HCl must be addressed when dealing with intrafamilial communication. Based on a review of the relevant literature

and of laws and guidelines from the USA, Canada, the UK, Australia, and various medical organizations, we have highlighted important points to consider when determining how to address intrafamilial communication of genetic risk in the clinical setting. To summarize, any duty on patients to disclose genetic risk information to family members should be personal, not legal, and should apply to a broad spectrum of family members and information. Health professionals can have an important role in conveying information to the patient, but the final decision of what, how, to whom, and when to disclose should remain with the patient to the extent possible. Genetic risk information is Captisol sensitive medical information and implicates both patients and others in their family. Strong reasons have not yet been provided to completely deprive patients of their traditional control over what happens to this information. This represents only an initial step towards fostering better communication within families.

Comments are closed.